PeptideStack
5.2kquestions
20kanswers
220users

Is ESSENCE a fair comparison of a GLP-1 receptor agonist against its comparator arm?

Asked 21 Apr 2024Modified 2.3 years agoViewed 29k times
This question was closed as needing detail or clarity.Closed 31 May 2024. Answers already posted are preserved; new answers are not accepted. Questions here need enough detail that they can be answered as written.
34

Setup, so nobody has to ask: ESSENCE · a GLP-1 receptor agonist.

This is asserted often enough that I assumed it was established, and then I went looking for the source.

I have searched the primary literature and found one paper that is adjacent but not on point.

Has anyone verified this independently?

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questionssemaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

470 questionstirzepatide
tirzepatide

A dual GIP and GLP-1 receptor agonist. Questions here cover the SURPASS and SURMOUNT programmes, the practical differences from a pure GLP-1…

370 questions
shareeditfollowflag
SF
askedshear_at_the_front17k2721 Apr 2024

No answers yet

This question has not been answered. It has been viewed 29k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.